Clinical Trial
Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck
- PMID: 3548960
Item in Clipboard
Clinical Trial
Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck
Cancer Treat Rep.
1987 Apr.
No abstract available
Similar articles
-
Phase II evaluation of diaziquone in recurrent head and neck cancer.Cancer Treat Rep. 1986 May;70(5):671-2. Cancer Treat Rep. 1986. PMID: 3708616 No abstract available.
-
Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer.Cancer Treat Rep. 1986 Aug;70(8):1039-40. Cancer Treat Rep. 1986. PMID: 3524834 Clinical Trial. No abstract available.
-
Phase II trial of pyrazofurin in advanced head and neck cancer.Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2047-8. Cancer Treat Rep. 1979. PMID: 526937 No abstract available.
-
Tiazofurin: biological effects and clinical uses.Int J Cell Cloning. 1990 May;8(3):161-70. doi: 10.1002/stem.5530080303. Int J Cell Cloning. 1990. PMID: 2189014 Review.
-
Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck.J Clin Oncol. 2006 Jun 10;24(17):2644-52. doi: 10.1200/JCO.2005.05.3348. J Clin Oncol. 2006. PMID: 16763278 Review.
Cited by
-
Clinical toxicity associated with tiazofurin.Invest New Drugs. 1990 May;8(2):227-38. doi: 10.1007/BF00177266. Invest New Drugs. 1990. PMID: 2200759 Review.
-
Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story.Cancers (Basel). 2019 Sep 11;11(9):1346. doi: 10.3390/cancers11091346. Cancers (Basel). 2019. PMID: 31514446 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical